Methyl-CCNU (NSCU-95441) versus methyl-CCNU plus cyclophosphamide (NSC-26271) in advanced gastrointestinal cancer
Rossi, A.; Riva, A.; Bonadonna, G.
Cancer ChemoTherapy Reports 59(6): 1161-1162
1975
ISSN/ISBN: 0069-0112 PMID: 769958 Document Number: 83975
Document emailed within 1 workday
Related Documents
Omura, G.A.; Shingleton, H.M.; Creasman, W.T.; Blessing, J.A.; Boronow, R.C. 1978: Chemotherapy of gynecologic cancer with nitrosoureas: a randomized trial of CCNU and methyl-CCNU in cancers of the cervix, corpus, vagina, and vulva Cancer Treatment Reports 62(5): 833-835Samson, M.K.; Baker, L.H.; Fraile, R.J.; Izbicki, R.M.; Vaitkevicius, V.K. 1977: Combination chemotherapy with cyclophosphamide, vincristine, methyl-CCNU, and bleomycin in advanced bronchogenic carcinoma: experience with 106 patients Cancer Treatment Reports 61(1): 59-64
Kane, R.C.; Cashdollar, M.R.; Bernath, A.M. 1978: Treatment of advanced colorectal cancer with methyl-CCNU plus 5-day 5-fluorouracil infusion Cancer Treatment Reports 62(10): 1521-1525
Gagliano, R.G.; Panettiere, F.J.; Haas, C.D.; Baker, L.; Hewlett, J.; Stuckey, W.J.; O'Bryan, R.M.; Bottomley, R.; Heilburn, L.K. 1981: Evaluation of beta-2'-deoxythioguanosine combined with methyl-CCNU or mitomycin in advanced colorectal cancer. a Southwest Oncology Group study Cancer Clinical Trials 4(4): 401-405
Buroker, T.; Baker, L.; Correa, J.; Schwartz, L.A.; Vailtkevicius, V.K. 1977: Phase i trial of ftorafur combined with mitomycin C or methyl-CCNU in gastrointestinal cancers Cancer Treatment Reports 61(3): 463-467
Didolkar, M.S.; Baffi, R.R.; Catane, R.; Kaufman, J.; Holyoke, E.D. 1977: Use of methyl-CCNU and procarbazine in advanced malignant melanoma resistant to DTIC therapy Cancer Treatment Reports 61(9): 1738-1739
Einhorn, L.H.; Furnas, B. 1977: Combination chemotherapy for disseminated malignant melanoma with DTIC, vincristine, and methyl-CCNU Cancer Treatment Reports 61(5): 881-883
Bernath, A.M.; Cohen, M.H.; Ihde, D.C.; Fossieck, B.E.; Matthews, M.J.; Minna, J.D. 1976: Combination chemotherapy with methyl-CCNU, 5-fluorouracil, and vincristine in adenocarcinoma and large cell carcinoma of the lung Cancer Treatment Reports 60(9): 1393-1394
Muss, H.B.; White, D.R.; Richards, F.; Cooper, M.R.; Spurr, C.L. 1976: Adriamycin and CCNU in the treatment of advanced breast cancer Cancer Treatment Reports 60(11): 1687-1689
Brun, B.; Kuentz, M.; Man, N.G.; Feuilhade, F.; Bierling, P.; Vernant, J.P.; Farcet, J.P.; Cordonnier, C.; Reyes, F.; Dreyfus, B.; Rochant, H. 1983: Multiple myeloma with high tumoral mass. Treatment combining melphalan, cyclophosphamide, vincristine, CCNU and prednisone. 35 cases Presse Medicale 12(19): 1205-1210
de Graeff, A.; de Groot, J.A.; Schornagel, J.H. 1987: Chemotherapy with doxorubicin and CCNU in advanced undifferentiated carcinoma of the nasopharynx. A retrospective report on five patients Netherlands Journal of Medicine 31(3-4): 111-116
Romanovich, A.I.; Chizhov, O.S.; Sviridov, A.F. 1988: Synthetic studies in the series of polyene macrolide antibiotics. 5. Synthesis of methyl-2,4,6-trideoxy-2,4-di-C-methyl-alpha-L- gluco-hexopyranoside and methyl-2,4,6-trideoxy-2,4-di-C-methyl- alpha-L-manno-hexopyranoside, the stereoisomers of the C33-C38 fragment of amphotericin B Bioorganicheskaia Khimiia 14(8): 1109-1112
Shih, W.W.; Baumhefner, R.W.; Tourtellotte, W.W.; Haskell, C.M.; Korn, E.L.; Fahey, J.L. 1983: Difference in effect of single immunosuppressive agents (cyclophosphamide, CCNU, 5-FU) on peripheral blood immune cell parameters and central nervous system immunoglobulin synthesis rate in patients with multiple sclerosis Clinical and Experimental Immunology 53(1): 122-132
Knight, W.A.; Loesch, D.M.; Leichman, L.P.; Fabian, C.; O'Bryan, R.M. 1982: Methyl-GAG in advanced colon cancer: a phase Ii trial of the Southwest Oncology Group Cancer Treatment Reports 66(12): 2099-2100
Zhang, S.R.; Xu, R.M.; Jin, B.Y.; Wu, Y.L.; Han, C. 1996: Protection of dl-(15R)-15 methyl-PGE2 methyl ester (PG6E) on experimental ulcers in rats Yao Xue Xue Bao 31(10): 746-750
Meng, X.Y.; Zhang, X.P.; Chen, X.H.; Yu, A.Z. 1991: Synthesis and antibacterial as well as antineoplastic activities of 2,4-diamino-5-methyl-6-(N-methyl-substituted benzyl) aminoquinazolines Yao Xue Xue Bao 26(5): 383-386
Colasanti, B.K.; Trotter, R.R. 1977: Enhanced ocular penetration of the methyl ester of (+/-) alpha-methyl-para-tyrosine after lontophoresis Archives Internationales de Pharmacodynamie et de Therapie 228(1): 171-176
De Amici, M.; De Micheli, C.; Grana, E.; Lucchelli, A.; Zonta, F. 1990: Nitrile oxides in medicinal chemistry. 3. Synthesis and bioenantioselectivity of (+)- and (-)-2-methyl-5-[(dimethylamino)-methyl]-3-oxo-isoxazolidine methiodide Farmaco 45(7-8): 859-866
Zalewska, A.; Winnicka, M.M.; Wiśniewski, K. 1996: Psychotropic activity of N-methyl-2-amino-4-phosphonobutyric acid (N-methyl AP4) Polish Journal of Pharmacology 48(4): 415-423
Blickens, D.A.; Riggi, S.J. 1971: Carbohydrate metabolism in normal and hyperglycemic animals treated with 1-methyl-4-(3-methyl-5-isoxazolyl)pyridinium chloride and phenformin Journal of Pharmacology and Experimental Therapeutics 177(3): 536-545